108.50p-0.50 (-0.46%)30 Jun 2022, 17:05
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Avacta Group PLC Market & Company News

30.06.2022 11:22AVCTAvacta's partner LG Chem renews licence to develop Affimer platformAlliance
30.06.2022 07:00AVCTLG Chem renews license triggers payment to AvactaRNS
29.06.2022 11:38DELT, SAE, AVCTAIM WINNERS & LOSERS: Deltic rises on Shell deal; Windar down on delayAlliance
29.06.2022 10:21AVCTAvacta shares up as cancer drug AVA6000 advances to third dose cohortAlliance
29.06.2022 09:05AVCTSecond Price Monitoring ExtnRNS
29.06.2022 09:00AVCTPrice Monitoring ExtensionRNS
29.06.2022 07:00AVCTSecond dose escalation in phase 1 trial of AVA6000RNS
23.06.2022 16:41AVCTSecond Price Monitoring ExtnRNS
23.06.2022 16:36AVCTPrice Monitoring ExtensionRNS
23.06.2022 16:27AVCTResult of Annual General MeetingRNS
16.06.2022 16:41AVCTSecond Price Monitoring ExtnRNS
16.06.2022 16:36AVCTPrice Monitoring ExtensionRNS
16.06.2022 16:03ZNWD, TND, RBGPUK shareholder meetings calendar - next 7 daysAlliance
31.05.2022 07:00AVCTPosting of Annual Report and Notice of AGMRNS
16.05.2022 14:04AVCTIN BRIEF: Avacta joint venture expands partnership with GenScriptAlliance
16.05.2022 12:00AVCTAffyXell expands partnership with GenScript ProBioRNS
11.05.2022 07:00AVCTLondon Therapeutics headquarters establishedReach
06.05.2022 07:00AVCTBlock Listing Application to AIM (update)RNS
28.04.2022 13:53AVCTBlock Listing Application to AIMRNS
14.04.2022 17:01AVCTIssue of Equity and Total Voting RightsRNS
14.04.2022 11:29AVCTIssue of Equity and Total Voting RightsRNS
13.04.2022 17:33AVCTAvacta increases shareholding in drug developer AffyXell to 22%Alliance
13.04.2022 07:00AVCTAffyXell milestone and increased equity stakeRNS
12.04.2022 07:00AVCTPoster presented at the AACR available to downloadRNS
11.04.2022 16:41AVCTSecond Price Monitoring ExtnRNS
11.04.2022 16:35AVCTPrice Monitoring ExtensionRNS
11.04.2022 14:05AVCTSecond Price Monitoring ExtnRNS
11.04.2022 14:00AVCTPrice Monitoring ExtensionRNS
08.04.2022 13:57AVCTIssue of Equity and Total Voting RightsRNS
08.04.2022 11:28JET2, AVCT, JNEOAIM WINNERS & LOSERS: Sensyne Health drops amid AIM delisting warningAlliance
08.04.2022 10:37AVCTAvacta joint venture to collaborate with Chinese biological companyAlliance
08.04.2022 07:00AVCTAffyXell partners with Biocytogen and KNTSCRNS
07.04.2022 16:31AVCTIssue of Equity and Total Voting RightsRNS
06.04.2022 10:23AVCTIN BRIEF: Avacta widens annual loss on research, manufacturing costsAlliance
06.04.2022 07:00AVCTPreliminary ResultsRNS
30.03.2022 16:41AVCTSecond Price Monitoring ExtnRNS
30.03.2022 16:35AVCTPrice Monitoring ExtensionRNS
30.03.2022 07:00AVCTNotice of Results and Investor PresentationRNS
29.03.2022 07:00AVCTAVA6000 data poster presentation at AACRRNS
21.03.2022 07:00AVCTDirectorate ChangeRNS
16.03.2022 11:38AVCTAvacta sells veterinary division to Vimian for up to GBP2.3 millionAlliance
16.03.2022 07:00AVCTVimian acquires Avacta’s Animal Health DivisionRNS
14.02.2022 16:41AVCTSecond Price Monitoring ExtnRNS
14.02.2022 16:36AVCTPrice Monitoring ExtensionRNS
07.02.2022 16:36AVCTPrice Monitoring ExtensionRNS
03.02.2022 17:26AVCTIssue of Equity and Total Voting RightsRNS
03.02.2022 16:41AVCTSecond Price Monitoring ExtnRNS
03.02.2022 16:35AVCTPrice Monitoring ExtensionRNS
03.02.2022 11:10AVCTAvacta shares up 12% after chemotherapy drug advances to next stageAlliance
03.02.2022 07:00AVCTDose escalation in the phase I trial of AVA6000RNS
31.01.2022 16:41AVCTSecond Price Monitoring ExtnRNS
31.01.2022 16:36AVCTPrice Monitoring ExtensionRNS
18.01.2022 07:00AVCTSecond pre|CISION Pro-drug Candidate SelectedRNS
12.01.2022 14:05AVCTSecond Price Monitoring ExtnRNS
12.01.2022 14:00AVCTPrice Monitoring ExtensionRNS
10.01.2022 07:00AVCTUpdate on AffiDX and detection of Omicron variantRNS
04.01.2022 11:06AVCTSecond Price Monitoring ExtnRNS
04.01.2022 11:01AVCTPrice Monitoring ExtensionRNS
22.12.2021 16:26AVCTIssue of Equity and Total Voting RightsRNS
22.12.2021 11:05AVCTSecond Price Monitoring ExtnRNS
22.12.2021 11:00AVCTPrice Monitoring ExtensionRNS
22.12.2021 07:00AVCTAffiDX Receives CE Mark for Consumer Self-TestingRNS
16.12.2021 07:00AVCTIssue of Equity and Total Voting RightsRNS
15.12.2021 07:00AVCTAffiDx® lateral flow test detects Omicron variantRNS
15.12.2021 07:00AVCTChange of auditorRNS
29.11.2021 07:00AVCTFDA Approval of IND Application for AVA6000RNS
18.11.2021 16:41AVCTSecond Price Monitoring ExtnRNS
18.11.2021 16:36AVCTPrice Monitoring ExtensionRNS
02.11.2021 07:00AVCTUpdate on UK Availability of AffiDX TestRNS
14.10.2021 16:36AVCTPrice Monitoring ExtensionRNS
14.10.2021 12:36AVCTIssue of Equity and Total Voting RightsRNS
30.09.2021 07:00AVCTInterim Results for the Period Ended 30 June 2021RNS
29.09.2021 07:00AVCTDevelopment Milestone in LG Chem PartnershipRNS
22.09.2021 16:41AVCTSecond Price Monitoring ExtnRNS
22.09.2021 16:35AVCTPrice Monitoring ExtensionRNS
Showing 1 to 75 of 134